Convalescent plasma for COVID-19 treatment - Why and How

Convalescent plasma for COVID-19 treatment - Why and How

A peer reviewed article discusses the use of convalescent plasma, i.e. passive polyclonal antibody (Ab) for treatment of COVID-19, as an effective, safe and successful treatment for COVID-19.

The article also outlines a brief methodology for treatment using convalescent plasma drawing upon the experience in France.

In India, Plasma therapy is about to be tested in a clinical trial in Kerala and Karnataka.

Tiberghien, P., de Lambalerie, X., Morel, P., Gallian, P., Lacombe, K. and Yazdanpanah, Y. (2020), Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how. Vox Sang. Accepted Author Manuscript. doi:10.1111/vox.12926

Share Tweet Send
You've successfully subscribed to COVID-19
Great! Next, complete checkout for full access to COVID-19
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.